This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Olipass Corporation. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Jeong-Seok Heo: Innovator in Antisense Oligonucleotides
Introduction
Jeong-Seok Heo is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents targeting skin aging.
Latest Patents
He holds a patent for "Acetyl-CoA carboxylase2 antisense oligonucleotides." This invention provides a peptide nucleic acid derivative that targets the 5' splice site of the human ACC2 pre-mRNA 'exon 12'. The derivatives described in this patent strongly induce splice variants of the human ACC2 mRNA in cells. They are particularly useful for treating conditions or disorders of skin aging associated with the human ACC2 protein.
Career Highlights
Jeong-Seok Heo is currently associated with Olipass Corporation, where he continues to advance his research and innovations. His work has the potential to impact the field of dermatology significantly.
Collaborations
He collaborates with talented individuals such as Myunghyo Hong and Dayoung Kang, contributing to a dynamic research environment.
Conclusion
Jeong-Seok Heo's innovative work in antisense oligonucleotides showcases his commitment to addressing skin aging through biotechnology. His contributions are paving the way for future advancements in therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile